Robin Condron

Biography

Robin Condron manages the Animal Health and Welfare portfolio in the Trade and Strategy Group of Dairy Australia and he contributes to the food safety and product integrity program. Robin provides leadership for policy development, strategic direction and high-level evidence informed analysis of issues for the Australian dairy industry in the areas of biosecurity, animal health, welfare and microbiological risks.

Robin Condron has considerable international experience. He is a past Chair of the International Dairy Federation Standing Committee on Microbiological Hygiene. He has contributed to Codex Alimentarius Commission Task Force on Antimicrobial Resistance and he launched the IDF Guide to Prudent Use of Antimicrobial Agents in Dairy Production at the OIE Global Conference on the Responsible and Prudent Use of Antimicrobial Agents for Animals in March 2013.

 

Abstract

Perspectives on Antimicrobial Resistance from Australia

Robin Condron

Dairy Australia, Melbourne

The Australian government has been an active participant in the development of the World Health Organisation Global Action Plan on antimicrobial resistance. This also includes ensuring the development and implementation of its own national antimicrobial resistance strategy 2015-2019, employing a national ‘One Health’ strategy. Minimising the development of antimicrobial resistance in livestock and companion animals is an essential component of Australia’s response and the dairy industry is fully engaged.

Australia has a conservative approach to antibiotic use in food producing animals and it is recognised that nationally Australia has a relatively low usage of antibiotics in agriculture when compared to other countries (fifth lowest use by countries for which data was available in the UK Report; J O’Neill 2015, ‘Antimicrobials in agriculture and the environment; reducing unnecessary use and waste’). A survey to monitor antibiotic use in Australia dairy cattle confirmed that first-line antibiotics are used predominantly (92% of total actives used) and that second-line antibiotics have limited use. Monitoring of dairy pathogens and enteric bacteria indicates a low and stable incidence of antimicrobial resistance.

Notwithstanding this favourable situation the Australia dairy industry contributes to the national strategy with initiatives including;

Continued commitment to the responsible and prudent use of antimicrobial agents ensures the dairy industry has access to effective treatments that are essential to treat dairy cattle and to protect the safety and integrity of dairy products.


Related Sessions